Radiotherapy in paediatric Cushing's disease: efficacy and long term follow up of pituitary function.
Pituitary radiotherapy (RT) is an effective second-line treatment for paediatric Cushing's disease (CD). We report long-term efficacy and anterior pituitary function in a cohort of paediatric CD patients treated with RT. Between 1988 and 2008, from our cohort of 48 paediatric CD patients, eight paediatric CD patients (5 males and 3 females) underwent second-line pituitary RT (45 Gy in 25 fractions), following unsuccessful transsphenoidal surgery. Out of eight whose long term follow up is available, four patients were cured by RT. Minimum follow up of 2 years is available for all patients. Four patients achieved cure after RT. Two patients were not cured even after follow up of 60 and 132 months, respectively. Out of four uncured patients, two of them had suppressible low dose dexamethasone cortisol with altered circadian rhythm suggesting possibility of response in near future with follow up of just 26 months. Five patients were hypogonadal and one patient was hypothyroid. All patients were below their target height at the time of last follow up. None of the patients had posterior pituitary dysfunction. This series of patients illustrates the efficacy and long-term follow up of pituitary function in children with CD treated with RT. This study also emphasizes the need of growth hormone statues assessment and timely intervention.
Acharya
Shrikrishna V
SV
Department of Endocrinology, Seth G S Medical College and KEM Hospital, Mumbai, 12 Maharashtra, India. drshri25@rediffmail.com
Gopal
Raju A
RA
Goerge
Joe
J
Menon
Padma S
PS
Bandgar
Tushar R
TR
Shah
Nalini S
NS
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D047748:Pituitary ACTH Hypersecretion / Q000532:radiotherapy*; D010902:Pituitary Gland / Q000378:metabolism / Q000503:physiopathology; D055815:Young Adult
Trends Endocrinol Metab. 1996 Aug;7(6):213-6
18406750
Clin Oncol (R Coll Radiol). 1993;5(6):393-4
8305364
J Clin Endocrinol Metab. 2000 Sep;85(9):3262-5
10999819
N Engl J Med. 1997 Jan 16;336(3):172-7
8988897
Clin Endocrinol (Oxf). 1999 Sep;51(3):265-71
10469003
N Engl J Med. 1977 Nov 3;297(18):957-62
909542
N Engl J Med. 1994 Sep 8;331(10):629-36
8052272
Clin Endocrinol (Oxf). 2004 Feb;60(2):169-74
14725677
Eur J Endocrinol. 2007 Apr;156(4):477-82
17389463
Acta Paediatr Scand. 1986 May;75(3):388-95
3014807
Horm Res. 2001;55 Suppl 1:24-30
11408758
Horm Res. 2005;64(3):140-3
16192738
J Clin Endocrinol Metab. 2003 Jan;88(1):34-7
12519825
Clin Endocrinol (Oxf). 1989 Sep;31(3):309-23
2559823
J Clin Endocrinol Metab. 1995 Aug;80(8):2475-9
7629245
Br Med J (Clin Res Ed). 1984 Apr 14;288(6424):1105-9
6424752
J Clin Endocrinol Metab. 2004 Aug;89(8):3818-20
15292311
J Clin Endocrinol Metab. 2003 Dec;88(12):5593-602
14671138
Clin Endocrinol (Oxf). 1999 Jul;51(1):61-6
10468966
Neurosurgery. 1996 Sep;39(3):484-92; discussion 492-3
8875478
J Clin Endocrinol Metab. 1997 Oct;82(10):3196-202
9329338
Lancet. 2006 May 13;367(9522):1605-17
16698415
Clin Endocrinol (Oxf). 1995 Jul;43(1):19-28
7641408
Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):307-14
7673017